Stockreport

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV [Financial Post (Toronto, Ontari...

Theratechnologies Inc. - Common Shares  (THTX) 
PDF Data Show Tesamorelin May Reduce CVD Risk by Reducing EVAF MONTREAL, Oct. 17, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (T [Read more]